These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 4044088)
1. Extended immunosuppression with cyclophosphamide using controlled-release polymeric implants. Ormrod DJ; Cawley S; Miller TE Int J Immunopharmacol; 1985; 7(4):443-8. PubMed ID: 4044088 [TBL] [Abstract][Full Text] [Related]
2. Sustained release of a corticosteroid using polymeric implants. Cawley S; Ormrod DJ; Paxton JW; Miller TE Agents Actions; 1986 Nov; 19(3-4):233-43. PubMed ID: 3825743 [TBL] [Abstract][Full Text] [Related]
3. Effects of subcutaneously implanted sustained-release cyclophosphamide capsules on Walker 256 solid rat tumor. Fu JC; Moyer DL; Cuevas J; Young R; Elshire D J Surg Oncol; 1977; 9(3):235-41. PubMed ID: 875393 [TBL] [Abstract][Full Text] [Related]
4. Immunotherapeutic effects of mangiferin mediated by the inhibition of oxidative stress to activated lymphocytes, neutrophils and macrophages. Muruganandan S; Lal J; Gupta PK Toxicology; 2005 Nov; 215(1-2):57-68. PubMed ID: 16076520 [TBL] [Abstract][Full Text] [Related]
5. Response of hematopoiesis to cyclophosphamide follows highly specific patterns in bone marrow and spleen. Sefc L; Psenák O; Sýkora V; Sulc K; Necas E J Hematother Stem Cell Res; 2003 Feb; 12(1):47-61. PubMed ID: 12662436 [TBL] [Abstract][Full Text] [Related]
6. Controlled release of local anesthetic from calcium phosphate bone cements. Irbe Z; Loca D; Vempere D; Berzina-Cimdina L Mater Sci Eng C Mater Biol Appl; 2012 Aug; 32(6):1690-4. PubMed ID: 24364978 [TBL] [Abstract][Full Text] [Related]
7. Changes in marrow myelopoietic and lymphoid cell counts after repeated cyclophosphamide administration in the rat. Berger J Haematologia (Budap); 1981 Dec; 14(4):407-16. PubMed ID: 7344975 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas. Judy KD; Olivi A; Buahin KG; Domb A; Epstein JI; Colvin OM; Brem H J Neurosurg; 1995 Mar; 82(3):481-6. PubMed ID: 7861228 [TBL] [Abstract][Full Text] [Related]
9. Experimental studies and preliminary clinical trial of vinorelbine-loaded polymeric bioresorbable implants for the local treatment of solid tumors. Fournier C; Hecquet B; Bouffard P; Vert M; Caty A; Vilain MO; Vanseymortier L; Merle S; Krikorian A; Lefebvre JL Cancer Res; 1991 Oct; 51(19):5384-91. PubMed ID: 1913658 [TBL] [Abstract][Full Text] [Related]
10. The in vitro and in vivo indomethacin release from self-setting bioactive glass bone cement. Otsuka M; Nakahigashi Y; Matsuda Y; Kokubo T; Yoshihara S; Fujita H; Nakamura T Biomed Mater Eng; 1997; 7(5):291-302. PubMed ID: 9457380 [TBL] [Abstract][Full Text] [Related]
12. Effective long-term immunosuppression in rats by subcutaneously implanted sustained-release tacrolimus pellet: effect on spinally grafted human neural precursor survival. Sevc J; Goldberg D; van Gorp S; Leerink M; Juhas S; Juhasova J; Marsala S; Hruska-Plochan M; Hefferan MP; Motlik J; Rypacek F; Machova L; Kakinohana O; Santucci C; Johe K; Lukacova N; Yamada K; Bui JD; Marsala M Exp Neurol; 2013 Oct; 248():85-99. PubMed ID: 23748136 [TBL] [Abstract][Full Text] [Related]
13. Extended levodopa release from a subcutaneously implanted polymer matrix in rats. Sabel BA; Dominiak P; Hüaser W; During MJ; Freese A Ann Neurol; 1990 Nov; 28(5):714-7. PubMed ID: 2260860 [TBL] [Abstract][Full Text] [Related]
14. Intravenous pulse administration of cyclophosphamide is an effective and safe treatment for sensitized cardiac allograft recipients. Itescu S; Burke E; Lietz K; John R; Mancini D; Michler R; Rose E; Oz M; Edwards N Circulation; 2002 Mar; 105(10):1214-9. PubMed ID: 11889016 [TBL] [Abstract][Full Text] [Related]
15. Gentamicin release from modified acrylic bone cements with lactose and hydroxypropylmethylcellulose. Virto MR; Frutos P; Torrado S; Frutos G Biomaterials; 2003 Jan; 24(1):79-87. PubMed ID: 12417181 [TBL] [Abstract][Full Text] [Related]
16. [Comparison of immunosuppression induced by different doses of cyclophosphamide in normal mice]. Qi L; Song Y; Wang W; Cui W; Zhang X; Liu Z; Sun N; Li N Wei Sheng Yan Jiu; 2010 May; 39(3):313-5, 325. PubMed ID: 20568461 [TBL] [Abstract][Full Text] [Related]
17. Effect of cyclophosphamide on a local graft-versus-host reaction in the rat: influence of sex, disease and different dosage regimens. Whitehouse MW; Levy L; Beck FJ Agents Actions; 1973 Jun; 3(2):53-60. PubMed ID: 4146937 [No Abstract] [Full Text] [Related]
18. [Immunosuppressive treatment of rheumatic diseases. Experimental bases of a rational concept of therapeutic approach (author's transl)]. Lemmel EM; Botzenhardt U Arzneimittelforschung; 1976; 26(7):1281-95. PubMed ID: 1087561 [TBL] [Abstract][Full Text] [Related]